IT8748643A0 - Composizioni farmaceutiche contenenti antagonisti di 5ht e ranitidina e relativo procedimento di produzione ed impiego - Google Patents

Composizioni farmaceutiche contenenti antagonisti di 5ht e ranitidina e relativo procedimento di produzione ed impiego

Info

Publication number
IT8748643A0
IT8748643A0 IT8748643A IT4864387A IT8748643A0 IT 8748643 A0 IT8748643 A0 IT 8748643A0 IT 8748643 A IT8748643 A IT 8748643A IT 4864387 A IT4864387 A IT 4864387A IT 8748643 A0 IT8748643 A0 IT 8748643A0
Authority
IT
Italy
Prior art keywords
ranitidine
antagonists
pharmaceutical compositions
compositions containing
use procedure
Prior art date
Application number
IT8748643A
Other languages
English (en)
Other versions
IT1211937B (it
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40347948&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8748643(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8748643A0 publication Critical patent/IT8748643A0/it
Application granted granted Critical
Publication of IT1211937B publication Critical patent/IT1211937B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT8748643A 1985-06-25 1987-11-27 Composizioni farmaceutiche contenenti antagonisti di 5ht e ranitidina e relativo procedimento di produzione ed impiego IT1211937B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858516083A GB8516083D0 (en) 1985-06-25 1985-06-25 Heterocyclic compounds
GB868628474A GB8628474D0 (en) 1985-06-25 1986-11-28 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IT8748643A0 true IT8748643A0 (it) 1987-11-27
IT1211937B IT1211937B (it) 1989-11-08

Family

ID=40347948

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8748643A IT1211937B (it) 1985-06-25 1987-11-27 Composizioni farmaceutiche contenenti antagonisti di 5ht e ranitidina e relativo procedimento di produzione ed impiego

Country Status (22)

Country Link
US (2) US4753789A (it)
EP (2) EP0226266B1 (it)
JP (2) JPS6253920A (it)
AT (2) ATE134510T1 (it)
AU (2) AU609028B2 (it)
BE (1) BE1002249A4 (it)
CA (1) CA1296637C (it)
CH (1) CH672068A5 (it)
CY (1) CY2000A (it)
DE (2) DE3650488T2 (it)
DK (1) DK624687A (it)
FR (1) FR2613934B1 (it)
GB (3) GB8516083D0 (it)
HK (1) HK82597A (it)
IE (1) IE60908B1 (it)
IL (1) IL84638A (it)
IT (1) IT1211937B (it)
NL (1) NL8702853A (it)
NZ (1) NZ222743A (it)
SE (1) SE8704747L (it)
SG (1) SG43311A1 (it)
ZA (1) ZA878927B (it)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
IL84845A0 (en) * 1986-12-17 1988-06-30 Glaxo Group Ltd Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
JPH0754759B2 (ja) * 1987-04-27 1995-06-07 日本電信電話株式会社 プラズマ処理方法および装置並びにプラズマ処理装置用モード変換器
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5039528A (en) * 1989-12-11 1991-08-13 Olney John W EAA antagonists as anti-emetic drugs
US4971651A (en) * 1990-02-05 1990-11-20 Hitachi, Ltd. Microwave plasma processing method and apparatus
AU2254692A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
PT533280E (pt) * 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina
JPH08507514A (ja) * 1993-03-08 1996-08-13 藤沢薬品工業株式会社 脳血管性疾患を治療または予防するための薬物
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CA2371822A1 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
KR100434390B1 (ko) * 2001-04-20 2004-06-04 안국약품 주식회사 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온을 유효성분으로 하는 비강분무용조성물
AU2003302072A1 (en) * 2002-11-15 2004-06-15 Helsinn Healthcare Sa Palonosetron for the treatment of chemotherapy-induced emesis
DE602004005814T2 (de) * 2003-01-13 2008-01-10 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
MY143789A (en) 2003-02-18 2011-07-15 Helsinn Healthcare Sa Use of palonosetron treating post- operative nausea and vomiting
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
CA2565854A1 (en) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
EP1940366B9 (en) * 2006-10-24 2009-12-02 Helsinn Healthcare S.A. Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
JP2010050046A (ja) 2008-08-25 2010-03-04 Hitachi High-Technologies Corp プラズマ処理装置
CN102892405A (zh) 2009-12-28 2013-01-23 莫诺索尔克斯有限公司 包含昂丹司琼的可经口施用的膜剂型
MX342993B (es) 2013-04-25 2016-10-13 Inst Mexicano Del Petróleo Proceso de obtencion de copolimeros aleatorios derivados del acido itaconico y/o sus isomeros y alquenil sulfonatos de sodio y uso del producto obtenido.
EP3589369A4 (en) 2017-01-09 2020-03-18 DAS-MG, Inc. USE AND COMPOSITION FOR TREATING MYASTHENIA GRAVIS AND OTHER MYASTHENIC SYNDROME

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
BE894285A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
DE3445377A1 (de) * 1983-12-23 1985-07-04 Sandoz-Patent-GmbH, 7850 Lörrach Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
IE57809B1 (en) * 1984-01-25 1993-04-21 Glaxo Group Ltd 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
AU583343B2 (en) * 1985-01-23 1989-04-27 Glaxo Group Limited Heterocyclic compounds
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
JPS63198623A (ja) 1988-08-17
EP0226266A3 (en) 1990-01-24
GB2200046A (en) 1988-07-27
IL84638A (en) 1992-05-25
EP0226266A2 (en) 1987-06-24
AU609028B2 (en) 1991-04-26
NL8702853A (nl) 1988-06-16
ATE134510T1 (de) 1996-03-15
AU8191487A (en) 1988-06-02
AU6703786A (en) 1988-06-30
GB8628474D0 (en) 1987-01-07
CA1296637C (en) 1992-03-03
AT395374B (de) 1992-12-10
DE3740351A1 (de) 1988-06-09
GB8727836D0 (en) 1987-12-31
HK82597A (en) 1997-06-27
GB8516083D0 (en) 1985-07-31
IE60908B1 (en) 1994-08-24
EP0226266B1 (en) 1996-02-28
DE3650488T2 (de) 1996-09-05
ZA878927B (en) 1988-10-26
BE1002249A4 (fr) 1990-11-06
EP0431443A3 (en) 1991-09-18
SE8704747L (sv) 1988-05-29
US4753789A (en) 1988-06-28
JPS6253920A (ja) 1987-03-09
US4929632A (en) 1990-05-29
ATA312587A (de) 1992-05-15
EP0431443A2 (en) 1991-06-12
CY2000A (en) 1997-12-05
FR2613934B1 (fr) 1993-07-09
DK624687D0 (da) 1987-11-27
GB2200046B (en) 1990-09-26
CH672068A5 (it) 1989-10-31
IT1211937B (it) 1989-11-08
DK624687A (da) 1988-05-29
FR2613934A1 (fr) 1988-10-21
JPH0324447B2 (it) 1991-04-03
NZ222743A (en) 1991-09-25
AU616386B2 (en) 1991-10-31
SE8704747D0 (sv) 1987-11-27
DE3650488D1 (de) 1996-04-04
IE873230L (en) 1988-05-28
SG43311A1 (en) 1997-10-17

Similar Documents

Publication Publication Date Title
IT8748643A0 (it) Composizioni farmaceutiche contenenti antagonisti di 5ht e ranitidina e relativo procedimento di produzione ed impiego
IT8648157A0 (it) Derivati del tiazolo, loro preparazione e composizioni farmaceutiche che li contengono
IT1232677B (it) Composizione farmaceutica contenente ranitidina
IT8548373A0 (it) Derivati amminopropossi,loro preparazione e loro impiego come medicamenti
IT8648446A0 (it) Tetraalchilpiperidine,loro preparazione e loro utilizzazione come stabilizzanti di materiali polimerici
IT1214754B (it) Derivati della calcitonina,loro preparazione e loro impiego come medicamenti
IT1203791B (it) Derivati del morfinano e della morfina,loro preparazione,loro impiego come medicamenti e e le composizioni farmaceutiche che li contengono
IT1203743B (it) Peptidi e derivati peptidici,loro preparazione e loro impiego come medicamenti
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
IL80339A0 (en) Benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IT1224226B (it) Derivati benzofuranici procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che li comprendono
IT8848133A0 (it) Preparazione e loro impiego come derivati della somatostatina, loro medicamenti
IT1197061B (it) Composizioni farmaceutiche ad azione vasodilatatrice e antianossica
IT1211967B (it) Composizione farmaceutica contenente ranitidina
IL79642A0 (en) Benzimidazole derivatives,their manufacture and pharmaceutical compositions containing them
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IT1203816B (it) Disaccaridi,loro preparazione e loro impiego come medicamenti
IT1190401B (it) Derivati di vitamina d,composizioni farmaceutiche che li contengono e loro precursori
IT8822493A0 (it) Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono
IT1201489B (it) Derivati di tiazolidina,loro procedimento di preparazione e formulazioni farmaceutiche
IT1196494B (it) Derivati dell'acito cef-3-em-4-carbossilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1182716B (it) Derivato di cefalosporina, composizione farmaceutica che lo contiene e relativo procedimento di preparazione ed applicazione
IT1200467B (it) Formulazione farmaceutica
IT1191931B (it) Derivati di isochinolina,composizioni che li contengono e relativo procedimento di produzione ed applicazione
IT1191986B (it) Derivati naftalenici di benzonorbornene loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971129